At a glance
- Originator British Biotech
- Class Anti-inflammatories; Immunotherapies; Neuroprotectants
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cachexia